Roninson Ib
Impact in
- Oncology top 5%
- Drug Transport and Resistance Mechanisms
- Transplantation top 5%
Papers in
- Oncology 6
- Drug Transport and Resistance Mechanisms 6
-
- Cancer therapeutics and mechanisms 3
- RNA Interference and Gene Delivery 2
- Co-authors
- Alexander Kolchinsky (1 shared paper)Tapani Ruutu (1 shared paper)Juha Kere (1 shared paper)Robert Winqvist (1 shared paper)Albert de la Chapelle (1 shared paper)Toru Watanabe (1 shared paper)Peter Atadja (1 shared paper)Noriko Uchiyama (1 shared paper)
- Journals
- Blood (3 papers)International Journal of Oncology (1 paper)PubMed (3 papers)
- Partner nations
- United StatesFinlandUnited Kingdom
In The Last Decade
Roninson Ib
7 papers receiving 798 citations
Peers
Comparison fields: 5 of 63
- Oncology 599
- Transplantation 52
- Virology 74
- Hematology 122
- Pediatrics, Perinatology and Child Health 182
Countries citing papers authored by Roninson Ib
This map shows the geographic impact of Roninson Ib's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Roninson Ib with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Roninson Ib more than expected).
Fields of papers citing papers by Roninson Ib
This network shows the impact of papers produced by Roninson Ib. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Roninson Ib. The network helps show where Roninson Ib may publish in the future.
Co-authors
The 9 scholars most cited alongside Roninson Ib, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 1992 | 312 | |
| 2 | 1992 | 258 | |
| 3 | Monoclonal antibodies against P-glycoprotein, an MDR1 gene product, inhibit interleukin-2 release from PHA-activated lymphocytes. | 1996 | 79 |
| 4 | 1989 | 68 | |
| 5 | Molecular mechanism of multidrug resistance in tumor cells. | 1987 | 60 |
| 6 | Drug resistance conferred by MDR1 expression in spheroids formed by glioblastoma cell lines. | 1998 | 36 |
| 7 | 2000 | 4 |
About Roninson Ib
Roninson Ib is a scholar working on Oncology, Molecular Biology, Genetics, Immunology and Infectious Diseases, having authored 7 papers that have together received 817 indexed citations. Recurring topics across this work include Drug Transport and Resistance Mechanisms (6 papers), Cancer therapeutics and mechanisms (3 papers), RNA Interference and Gene Delivery (2 papers), Nanoparticle-Based Drug Delivery (1 paper), Hemoglobinopathies and Related Disorders (1 paper), HIV/AIDS drug development and treatment (1 paper), Myeloproliferative Neoplasms: Diagnosis and Treatment (1 paper) and Cancer Research and Treatments (1 paper). The work is most often cited by research in Oncology (599 citations), Transplantation (52 citations), Virology (74 citations), Hematology (122 citations) and Pediatrics, Perinatology and Child Health (182 citations). Roninson Ib has collaborated with scholars based in United States, Finland and United Kingdom. Frequent co-authors include Alexander Kolchinsky, Tapani Ruutu, Juha Kere, Robert Winqvist, Albert de la Chapelle, Toru Watanabe, Peter Atadja, Noriko Uchiyama and Dalia Cohen. Their work appears in journals such as Blood, International Journal of Oncology and PubMed.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.